Second era of molecular-targeted cancer therapies in dogs.

J Vet Med Sci · 2023 · PMC10466056 · PMID 37380433

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

The number of papers on clinical trials of molecular-targeted drugs in dogs and cats, rather than in cell lines or cancer-bearing mouse models, shows an interesting trend: there were zero to a few papers in the 1990s and the early 2000s, and the number of papers gradually increased around 2009.

also in 497 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.